Cystatin C is involved in the extracellular inhibition of cathepsin and removed from the circulation by tubular cells in the kidneys, which resulted in the identification of this protein as a biomarker for renal dysfunction and cardiovascular disease [34, 35]. This evidence concerns the gene CTSS and Abnormal renal physiology.